PRESS: Britain could be getting high on the benefits of a full-scale medical cannabis industry
The UK has an incredible opportunity to improve patients’ lives through cannabis-based medicines for some of the most debilitating conditions, such as chronic pain.
Celadon Pharmaceuticals Plc is at the forefront of building this new pharmaceutical sector. We have a simple approach: high-quality UK cultivation and API manufacturing, clinical trials, and R&D into cannabinoids.
We need others in this journey – regulators, universities, pharmaceutical companies, and the government. The prize is worth it: patients’ quality of life across the UK.
Continue reading on City AM by Clicking Here.